Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | GPNMB |
| Upstream (Parents) |
|---|
| (<<) VIM → GPNMB |
| (<<) TM6SF1 → GPNMB |
| (<<) LAPTM5 → GPNMB |
| (<<) TREM2 → GPNMB |
| (<<) CD37 → GPNMB |
| Downstream (Children) |
|---|
| GPNMB → HS3ST2 (>>) |
| GPNMB → AOC2 (>>) |
| GPNMB → DAB2 (>>) |
| GPNMB → VIM (>>) |
| GPNMB → ADH7 (>>) |
| GPNMB → PNMT (>>) |
| GPNMB → CHIT1 (>>) |
| GPNMB → ADAMDEC1 (>>) |
| GPNMB → FAM70A (>>) |
| GPNMB → CCL18 (>>) |
| GPNMB → TREM2 (>>) |
| GPNMB → CD22 (>>) |
| GPNMB → SLC2A6 (>>) |
| GPNMB → OLR1 (>>) |
| GPNMB → ACP5 (>>) |
